Noetik
Noetik is an AI-native biotech company using self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics. They've built a discovery and development platform combining human multimodal spatial omics data with a CRISPR perturbation platform to train foundation models of tissue and tumor biology. This fuels their discovery of novel cancer therapeutic candidates.
Funding Round: Series A
Funding Amount: $40M
Date: 29-Aug-2024
Investors: Polaris Partners, Khosla Ventures, Wittington Ventures, Breakout Ventures, DCVC, Zetta Venture Partners, Catalio Capital Management, 11.2 Capital, Epic Ventures, Intermountain Ventures, North South Ventures, ApSTAT Technologies, Linearis Labs and Ventures Fund
Markets: Biotechnology, AI, Oncology, Life Science, Drug Discovery, Other Healthcare Technology Systems, Big Data, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
HQ: South San Francisco, California, United States
Founded: 2022
Website: https://www.noetik.ai/
LinkedIn: https://www.linkedin.com/company/noetik-inc
Twitter: https://twitter.com/noetik_ai
Crunchbase: https://www.crunchbase.com/organization/noetik
Leave a Comment
Comments
No comments yet.